While the resumption of competitive sport in the U.S. ultimately depends on public health policy, it is evident that the cardiovascular management of athletes recovering from COVID-19, including return-to-play, poses numerous and significant challenges.

Unfortunately, essential questions currently lack evidenced-based answers.

In this expert opinion piece, Jonathan H. Kim, MD, MSc, FACC, discusses the ripple effects stemming from COVID-19 impact all aspects of health care.

For sports medicine practitioners and sports cardiologists, COVID-19 has forced them to reconsider their algorithmic approach to the pre-participation cardiac evaluation, the symptomatic athlete and return to play. Read more.